Role of training dose in drug discrimination: A review

Behavioural Pharmacology

Volumn 22, Issue 5-6, 2011, Pages 415-429

  Stolerman, Ian P ^a   Childs, Emma ^b   Ford, Matthew M ^c   Grant, Kathleen A ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CHICAGO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

c aminobutyric acid mimetics; cannabinoids; drug discrimination; ethanol; hallucinogens; nicotine; opioids; psychomotor stimulants; review

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ALCOHOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CAFFEINE; CANNABINOID; CENTRAL STIMULANT AGENT; COCAINE; FENTANYL; FLUMAZENIL; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; N ALLYLNORMETAZOCINE; NALOXONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NICOTINE; OPIATE; PANADIPLON; PENTOBARBITAL; PHENCYCLIDINE; PIZOTIFEN; PSYCHEDELIC AGENT; RIMONABANT; RO 1788; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CENTRAL NERVOUS SYSTEM; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL DETECTION; STIMULUS;

ANALGESICS, OPIOID; ANIMALS; BARBITURATES; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HALLUCINOGENS; HUMANS; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN;

EID: 80051942961     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328349ab37     Document Type: Review

References (157)

1. Ator NA (1991). Discriminative stimulus effects of the novel anxiolytic buspirone. Behav Pharmacol 2:3-14.
2. Ator NA, Griffiths RR (1989). Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam. Psychopharmacology (Berl) 98:20-30. (Pubitemid 19117339)
3. Barrett RJ, Steranka LR (1983). Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol. Pharmacol Biochem Behav 18:611-617. (Pubitemid 13128881)
4. Batman AM, Munzar P, Beardsley PM (2005). Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology (Berl) 179:393-401. (Pubitemid 40569044)
5. Beardsley PM, Balster RL (1988). Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine. J Pharmacol Exp Ther 244:34-40. (Pubitemid 18042359)
6. Beardsley PM, Balster RL, Salay JM (1987). Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination. J Pharmacol Exp Ther 241:159-165. (Pubitemid 17119355)
7. Bondarev ML, Bondareva TS, Young R, Glennon RA (2003). Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol 474:85-93. (Pubitemid 37289149)
8. Bowen CA, Purdy RH, Grant KA (1999a). Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: effect of ethanol training dose and dosing procedure. J Pharmacol Exp Ther 289:405-411. (Pubitemid 29156056)
9. Bowen CA, Purdy RH, Grant KA (1999b). An investigation of endogenous neuroactive steroid-induced modulation of ethanol's discriminative stimulus effects. Behav Pharmacol 10:297-311. (Pubitemid 29301265)
10. Broqua P, Wettstein JG, Rocher MN, Rivière PJM, Dahl SG (1998). The discriminative stimulus properties of U50488 and morphine are not shared by fedotozine. Eur Neuropsychopharmacol 8:261-266. (Pubitemid 28557018)
11. Bruner NR, Anderson KG (2009). Discriminative stimulus and time-course effects of kava-kava (Piper methysticum) in rats. Pharmacol Biochem Behav 92:297-303.
12. Callahan PM, Piercey MF, Cunningham KA (1992). Effects of the putative dopamine autoreceptor antagonists ( + )-AJ76 and ( + )-UH 232 on the discriminative stimulus properties of cocaine. Psychopharmacology (Berl) 107:73-77.
13. Cameron OG, Appel JB (1973). A behavioral and pharmacological analysis of some discriminable properties of LSD in rats. Psychopharmacologia (Berl) 33:117-134.
14. Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977). A description of the nicotine stimulus and tests of its generalization to amphetamine. Psycho-pharmacology (Berl) 55:19-26. (Pubitemid 8223197)
15. Colombo G, Agabio R, Bourguignon J, Fadda F, Lobina C, Maitre M, et al. (1995). Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Physiol Behav 58: 587-590.
16. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998). Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302. (Pubitemid 28458951)
17. Colpaert FC, Janssen PAJ (1982). Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in cocaine-saline discrimination. Neuropharmacology 21:1187-1194. (Pubitemid 13234622)
18. Colpaert FC, Janssen PAJ (1983). A characterization of LSD-antagonist effects of pirenperone in the rat. Neuropharmacology 22:1001-1005. (Pubitemid 13039235)
19. Colpaert FC, Janssen PAJ (1986). Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination. Psychopharmacology (Berl) 90:222-228. (Pubitemid 16011359)
20. Colpaert FC, Niemegeers CJE, Janssen PAJ (1976a). The narcotic discriminative stimulus complex: relation to analgesic activity. J Pharm Pharmacol 28: 183-187.
21. Colpaert FC, Niemegeers CJE, Janssen PAJ (1976b). Theoretical and methodological considerations on drug discrimination learning. Psychophar-macology (Berl) 46:169-177.
22. Colpaert FC, JJMD Kuyps, Niemegeers CJE, Janssen PAJ (1976c). Discriminative stimulus properties of a low dl-amphetamine dose. Arch Int Pharmacodyn Ther 223:34-42.
23. Colpaert FC, Niemegeers CJE, Janssen PAJ (1980a). Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination. J Pharmacol Exp Ther 212:474-480. (Pubitemid 10016554)
24. Colpaert FC, Niemegeers CJE, Janssen PAJ (1980b). Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination. Neuropharmacology 19:705-713. (Pubitemid 10040276)
25. Colpaert FC, Niemegeers CJE, Janssen PAJ (1982). A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206-214. (Pubitemid 12156493)
26. Cook CD, Picker MJ (1998). Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist ( ± )-7-OH-DPAT. Psychopharmacology (Berl) 136:59-69.
27. Costanza RM, Barber DJ, Terry P (2001). Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. Psychopharmacology (Berl) 158:146-153. (Pubitemid 33020833)
28. Craft RM, Stratmann JA (1996). Discriminative stimulus effects of cocaine in female versus male rats. Drug Alcohol Depend 42:27-37. (Pubitemid 26300637)
29. Craft RM, Kalivas PW, Stratmann JA (1996). Sex differences in discriminative stimulus effects of morphine in the rat. Behav Pharmacol 7:764-778. (Pubitemid 27219684)
30. Cunningham CS, Polston JE, Jany JR, Segert IL, Miller DK (2006). Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine. Drug Alcohol Depend 84: 211-222. (Pubitemid 44287210)
31. De Vry J, Jentzsch KR (2003). Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm. Behav Pharmacol 14:471-476. (Pubitemid 37176805)
32. De Vry J, Slangen JL (1986a). Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure. Psychopharmacology (Berl) 88:177-183. (Pubitemid 16148132)
33. De Vry J, Slangen JL (1986b). Effects of training dose on discrimination and cross-generalization of chlordiazepoxide, pentobarbital and ethanol in the rat. Psychopharmacology (Berl) 88:341-345. (Pubitemid 16131121)
34. Desai RI, Barber DJ, Terry P (2003). Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psycho-pharmacology (Berl) 167:335-343. (Pubitemid 36754234)
35. Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, Miller DK (2007). Modafinil evokes striatal [3H]dopamine release and alters the subjective properties of stimulants. Eur J Pharmacol 568:112-123. (Pubitemid 46976895)
36. Gaiardi M, Gubellini C, Dall'Olio R, Gandolfi O, Bartoletti M (2001). Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine. Behav Pharmacol 12:317-324. (Pubitemid 32983504)
37. Gasior M, Shoaib M, Yasar S, Jaszyna M, Goldberg SR (1999). Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288:1053-1073. (Pubitemid 29254143)
38. Gauvin DV, Young AM (1989). Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berl) 98:212-221. (Pubitemid 19137734)
39. Ginsburg BC, Lamb RJ (2005). Alphaxalone and epiallopregnanolone in rats trained to discriminate ethanol. Alcohol Clin Exp Res 29:1621-1629. (Pubitemid 41395611)
40. Goudie AJ, Smith JA, Cole JC (2004). Stimulus properties of the 'atypical' antipsychotic zotepine in rats: comparison with clozapine and quetiapine. Pharmacol Biochem Behav 77:163-173. (Pubitemid 38076993)
41. Grabus SD, Smurthwaite ST, Riley AL (1999). Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose. Pharmacol Biochem Behav 63:481-488. (Pubitemid 29287167)
42. Grant KA (1999). Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol Biochem Behav 64:261-267. (Pubitemid 29438610)
43. Grant KA, Colombo G (1993a). Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. J Pharmacol Exp Ther 264:1241-1247. (Pubitemid 23318617)
44. Grant KA, Colombo G (1993b). Substitution of the 5-HT1 agonist trifluor-omethylphenylpiperazine (TFMPP) for the discriminative stimulus effects of ethanol: effects of training dose. Psychopharmacology (Berl) 113: 26-30. (Pubitemid 23341041)
45. Grant KA, Colombo G (1993c). Pharmacological analysis of the mixed discriminative stimulus effects of ethanol. Alcohol Alcohol (Suppl) 2: 445-449.
46. Grant KA, Colombo G, Gatto GJ (1997). Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose. Psychopharmacology (Berl) 133:133-141. (Pubitemid 27404743)
47. Grant KA, Waters CA, Green-Jordan K, Azarov A, Szeliga KT (2000). Characterization of the discriminative stimulus effects of GABAA receptor ligands in Macaca fascicularis monkeys under different ethanol training conditions. Psychopharmacology (Berl) 152:181-188.
48. Green KL, Grant KA (1998). Evidence for overshadowing by components of the heterogenous discriminative stimulus effects of ethanol. Drug Alcohol Depend 52:149-159. (Pubitemid 28529494)
49. Green KL, Grant KA (1999). Effects of L-type voltage-sensitive calcium channel modulators on the discriminative stimulus effects of ethanol in rats. Alcohol Clin Exp Res 23:806-814. (Pubitemid 29256566)
50. Green KL, Gatto GJ, Grant KA (1997). The nitric oxide synthase inhibitor L-NAME (N-nitro-L-arginine methyl ester) does not produce discriminative stimulus effects similar to ethanol. Alcohol Clin Exp Res 21:483-488. (Pubitemid 27217193)
51. Green-Jordan KL, Grant KA (2000). Modulation of the ethanol-like discriminative stimulus effects of diazepam and phencyclidine by L-type voltage gated calcium channel ligands in rats. Psychopharmacology 149:84-92. (Pubitemid 30187371)
52. Greenberg I, Kuhn DM, Appel JB (1975). Behaviorally induced sensitivity to the discriminable properties of LSD. Psychopharmacologia (Berl ) 43:229-232.
53. Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, et al. (1990). Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther 252:970-978. (Pubitemid 20127398)
54. Helms CM, Rogers LSM, Grant KA (2008a). Gamma-hydroxybutyric acid in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol. Behav Pharmacol 19:317-324.
55. Helms CM, Rogers LSM, Waters CA, Grant KA (2008b). Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol. Alcohol Clin Exp Res 32:1197-1206.
56. Hirschhorn ID, Rosecrans JA (1974). Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine. Psychopharmacologia (Berl) 40:109-120.
57. Holtzman SG (1986). Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J Pharmacol Exp Ther 239:706-714. (Pubitemid 17225836)
58. Holtzman SG (1997). Discriminative stimulus effects of buprenorphine in the rat. Psychopharmacology (Berl) 130:292-299. (Pubitemid 27170363)
59. Jackson A, Sanger DJ (1988). Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-d-aspartate receptors? Psychopharmacology (Berl) 96:87-92.
60. Järbe TUC (1989). Discrimination learning with drug stimuli. In: Boulton AA, Baker GB, Greenshaw AJ, editors. Neuromethods, Psychopharmacology. Vol. 13: Clifton, New Jersey: Humana Press. pp. 513-563.
61. Järbe TUC, Johansson B (1984). Interaction between drug discriminative stimuli and exteroceptive, sensory signals. Behav Neurosci 98:686-694. (Pubitemid 14037794)
62. Järbe TUC, Swedberg MDB (1998). Discriminative stimulus functions of CNS sedative drugs assessed by drug versus drug discrimination procedures in gerbils. Psychopharmacology (Berl) 135:201-212. (Pubitemid 28055504)
63. Järbe TUC, Lamb RJ, Makriyannis A, Lin S, Goutopolos A (1998). Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology (Berl) 140:519-522. (Pubitemid 28566852)
64. Järbe TUC, Lamb RJ, Lin S, Makriyannis A (2001). (R)-methanandamide and delta9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psycho-pharmacology (Berl) 156:369-380. (Pubitemid 32695845)
65. 9-THC and (R)-methanandamide in rats. Psychopharmacology (Berl) 184: 36-45. (Pubitemid 43005755)
66. Jä rbe TUC, Lamb RJ, Liu Q, Makriyannis A (2006b). Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with delta9-THC or (R)-methanandamide (AM-356). Psychopharmacology (Berl) 188:315-323. (Pubitemid 44387459)
67. Jä rbe TUC, Li C, Liu Q, Makriyannis A (2009). Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide. Psychopharma-cology (Berl) 203:229-239.
68. Järbe TUC, Gifford RS, Makriyannis A (2010). Antagonism of the D9-THC behavioral effects by rimonabant: time course studies in rats. Eur J Pharmacol 648:133-138.
69. Jones CN, Howard JL, McBennett ST (1980). Stimulus properties of antidepressants in the rat. Psychopharmacology (Berl) 67:111-118. (Pubitemid 10135173)
70. Jones HE, Bigelow GE, Preston KL (1999). Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure. J Pharmacol Exp Ther 289:1350-1361. (Pubitemid 29246664)
71. Kantak KM, Edwards MA, Spealman RD (1995). Effects of n-methyl-d-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists. J Pharmacol Exp Ther 274: 657-665.
72. Kantak KM, Riberdy A, Spealman RD (1999). Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine. Psycho-pharmacology (Berl) 147:257-265. (Pubitemid 30010545)
73. Kleven MS, Koek W (1997). Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists. Psychopharmacology (Berl) 131:307-312. (Pubitemid 27283593)
74. Kleven MS, Koek W (1998). Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025. (Pubitemid 28130830)
75. Koek W, Slangen JL (1982). The role of fentanyl training dose and of the alternative stimulus condition in drug generalization. Psychopharmacology (Berl) 76:149-156. (Pubitemid 12142999)
76. Koek W, Woods JH (1989). Partial generalization in pigeons trained to discriminate morphine from saline. Drug Dev Res 16:169-181. (Pubitemid 19157804)
77. Koek W, Woods JH, Jacobson AE, Rice KC (1987). Phencyclidine (PCP) like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonova-lerate in pigeons: generality across different training doses of PCP. Psychopharmacology (Berl) 93:437-442. (Pubitemid 18049581)
78. Koek W, Chen W, Mercer SL, Coop A, France CP (2006). Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317:409-417.
79. Kollins SH, Rush CR (1999). Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. Pharmacol Biochem Behav 64:319-326. (Pubitemid 29438617)
80. Krimmer EC, McGuire MS, Barry HI (1984). Effects of the training dose on generalization of morphine stimulus to clonidine. Pharmacol Biochem Behav 20:669-673. (Pubitemid 14148188)
81. Le Foll B, Goldberg SR (2005). Ethanol does not affect discriminative-stimulus effects of nicotine in rats. Eur J Pharmacol 519:96-102. (Pubitemid 43181171)
82. Mackintosh NJ (1974). The Psychology of Animal Learning. New York: Academic Press.
83. Mansbach RS, Balster RL (1991). Pharmacological specificity of the phen-cyclidine discriminative stimulus in rats. Pharmacol Biochem Behav 39: 971-975.
84. Mansbach RS, Chambers LK, Rovetti CC (2000). Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine. Psychopharmacology (Berl) 148:234-242. (Pubitemid 30136730)
85. Mariathasan EA, Stolerman IP (1993). Overshadowing of nicotine discrimination in rats: a model for behavioural mechanisms of drug interactions? Behav Pharmacol 4:209-215. (Pubitemid 23181740)
86. McMillan DE, Hardwick WC, Li M (2001). Discrimination of pentobarbital doses and drug mixtures under fixed-ratio and fixed-interval reinforcement schedules. Behav Pharmacol 12:195-208. (Pubitemid 32619881)
87. Meisch RA, Stolerman IP, Tsibulsky V (2011). Comprehensive drug self-administration and discrimination database. www.drugrefs.org, (Accessed on March 2011).
88. Meltzer LT, Rosecrans JA, Aceto MD, Harris LS (1980). Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology (Berl) 68:283-286. (Pubitemid 10124224)
89. Morgan D, Cook CD, Picker MJ (1999). Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor. J Pharmacol Exp Ther 289:965-975. (Pubitemid 29191255)
90. Mumford GK, Holtzman SG (1991). Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857-865.
91. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, et al. (1994). Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology (Berl) 115:1-8. (Pubitemid 24207754)
92. Murray JE, Bevins RA (2007). Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. Eur J Pharmacol 561:91-104. (Pubitemid 46435861)
93. Nielsen EB, White FJ, Holohean AM, Callahan PM, Appel JB (1982). Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines. Life Sci 31:2433-2439. (Pubitemid 13168691)
94. Overton DA (1974). Experimental methods for the study of state-dependent learning. Fed Proc 33:1800-1813.
95. Overton DA (1975). A comparison of the discriminable CNS effects of keta-mine, phencyclidine and pentobarbital. Arch Int Pharmacodyn Ther 215: 180-189.
96. Overton DA (1977). Comparison of ethanol, pentobarbital and phenobarbital using drug versus drug discrimination training. Psychopharmacology (Berl) 53:195-199. (Pubitemid 8141887)
97. Overton DA, Batta SK (1979). Investigation of narcotics and antitussives using drug discrimination techniques. J Pharmacol Exp Ther 211:401-408. (Pubitemid 10206632)
98. Perkins KA, D'Amico D, Sanders M, Grobe JE, Wilson A, Stiller RL (1996). Influence of training dose on nicotine discrimination in humans. Psychophar-macology (Berl) 126:132-139. (Pubitemid 26246763)
99. Picker MJ (1991). Discriminative stimulus properties of ( + )-and (-)-n-allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds. Behav Pharmacol 2:497-511.
100. Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA (1990). Discriminative stimulus properties of U50488 and morphine effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther 254:13-22.
101. Picker MJ, Craft RM, Negus SS, Powell KR, Mattox SR, Jones SR, et al. (1992). Intermediate efficacy Mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats. J Pharmacol Exp Ther 263:668-681.
102. Picker MJ, Yarborough J, Hughes CE, Smith MA, Morgan D, Dykstra LA (1993). Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J Pharmacol Exp Ther 266:756-767. (Pubitemid 23318688)
103. Picker MJ, Smith MA, Morgan D (1994). Assessment of the relative intrinsic efficacy of profadol and meperidine in a pigeon drug discrimination procedure: relevance to partial substitution patterns. Behav Pharmacol 5:61-70. (Pubitemid 24125226)
104. Porter JH, Villanueva HF, Rosecrans JA (1999). Role of D1 and D2 dopamine receptors in the discriminative stimulus properties of the atypical antipsycho-tic clozapine in rats. Drug Dev Res 46:139-147. (Pubitemid 29207273)
105. Porter JH, McCallum SE, Varvel SA, Vann RE (2000). The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacol-ogy (Berl) 148:224-233. (Pubitemid 30136729)
106. Powell KR, Koppelman LF, Holtzman SG (1999). Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats. Behav Pharmacol 10:707-716. (Pubitemid 30028744)
107. Preston KL, Bigelow GE (1998). Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533-543. (Pubitemid 28552547)
108. Prus AJ, Baker LE, Meltzer HY (2004). Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Pharmacol Biochem Behav 77:199-208. (Pubitemid 38125151)
109. Prus AJ, Philibin SD, Pehrson AL, Porter JH (2005). Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task. Behav Pharmacol 16: 511-520. (Pubitemid 41416070)
110. Prus AJ, Philibin SD, Pehrson AL, Porter JH (2006). Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle. Behav Pharmacol 17:185-194.
111. Quertemont E, Grant KA (2002). Role of acetaldehyde in the discriminative stimulus effects of ethanol. Alcohol Clin Exp Res 26:812-817. (Pubitemid 34666140)
112. Quertemont E, Green HL, Grant KA (2003). Brain ethanol concentrations and ethanol discrimination in rats: effects of dose and time. Psychopharmacology (Berl) 168:262-270. (Pubitemid 36920909)
113. Quinton MS, Gerak LR, Moerschbaecher JM, Winsauer PJ (2006). Effects of pregnanolone in rats discriminating cocaine. Pharmacol Biochem Behav 85:385-392. (Pubitemid 44881079)
114. Rowlett JK, Wilcox KM, Woolverton WL (1999). Discriminative stimulus effects of ethyl-beta-carboline-3-carboxylate at two training doses in rats. Psychophar-macology (Berl) 145:324-332. (Pubitemid 29393483)
115. Rush CR, Critchfield TS, Troisi JR II, Griffiths RR (1995). Discriminative stimulus effects of diazepam and buspirone in normal volunteers. J Exp Anal Behav 63:277-294.
116. Sanger DJ (1988). Behavioural effects of the alpha-2 adrenoreceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine. Psycho-pharmacology (Berl) 96:243-249.
117. Sanger DJ, Zivkovic B (1994). Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic. Psychopharmacology (Berl) 113:395-403. (Pubitemid 24150486)
118. Sannerud CA, Ator NA (1995a). Drug discrimination analysis of midazolam under a three-lever procedure: dose dependent differences in generalization and antagonism. J Pharmacol Exp Ther 272:100-111.
119. Sannerud CA, Ator NA (1995b). Drug discrimination analysis of midazolam under a three-lever procedure II: differential effects of benzodiazepine receptor agonists. J Pharmacol Exp Ther 275:183-193.
120. Schechter MD (1997). Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants. Pharmacol Biochem Behav 56:457-463. (Pubitemid 27145826)
121. Shannon HE, Holtzman SG (1979). Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacol-ogy (Berl) 61: 239-244. (Pubitemid 9227014)
122. Shannon HE, Herling S (1983). Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J Pharmacol Exp Ther 227:160-166. (Pubitemid 14205284)
123. Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002). The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530-539. (Pubitemid 34304245)
124. Smith MA, Picker MJ (1995). Examination of the kappa agonist and antagonist properties of opioids in the rat drug discrimination procedure: influence of training dose and intrinsic efficacy. Behav Pharmacol 6:703-717.
125. Smith JW, Stolerman IP (2009). Recognising nicotine: the neurobiological basis of nicotine discrimination. In: Henningfield JE, London ED, Pogun S, editors. Nicotine Psychopharmacology. Berlin: Springer-Verlag. pp. 295-333.
126. Smith JA, Boyer-Millar C, Goudie AJ (1999). Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics? Pharmacol Biochem Behav 64:429-433. (Pubitemid 29438634)
127. Snoddy AM, Tessel RE (1983). Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205-210. (Pubitemid 13011184)
128. Spealman RD (1995). Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62.
129. Spealman RD, Bergman J (1994). Opioid modulation of the discriminative stimulus effects of cocaine: comparison of mu, kappa and sigma agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol 5:21-31. (Pubitemid 24125222)
130. Stadler JR, Caul WF, Barrett RJ (2001). Effects of training dose on amphetamine drug discrimination: dose-response functions and generalization to cocaine. Pharmacol Biochem Behav 70:381-386. (Pubitemid 33049950)
131. Stolerman IP, D'Mello GD (1981). Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology (Berl) 73:295-303. (Pubitemid 11104049)
132. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984). Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacol-ogy (Berl) 84:413-419. (Pubitemid 15205971)
133. Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999). Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology (Berl) 141:297-306. (Pubitemid 29196079)
134. Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004). The role of nicotinic receptor alpha7 subunits in nicotine discrimination. Neuropharmacology 46:363-371. (Pubitemid 38223869)
135. Szeliga KT, Grant KA (1998). Analysis of the 5-HT2 receptor ligands dimethoxy-4-indophenyl-2-aminopropane and ketanserin in ethanol discriminations. Alcohol Clin Exp Res 22:646-651. (Pubitemid 28242470)
136. Tang AH, Franklin SR (1991). The discriminative stimulus effects of diazepam in rats at two training doses. J Pharmacol Exp Ther 258:926-931.
137. Terry P, Witkin JM, Katz JL (1994). Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048. (Pubitemid 24315218)
138. Vanecek SA, Young AM (1995). Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behav Pharmacol 6:669-681.
139. Vivian JA, Waters CA, Szeliga KT, Jordan K, Grant KA (2002). Characterization of the discriminative stimulus effects of N-methyl-D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey (Macaca fascicularis). Psychopharmacology (Berl) 162:273-281. (Pubitemid 34762286)
140. Walker EA, Young AM (1993). Discriminative-stimulus effects of the low efficacy Mu agonist nalbuphine. J Pharmacol Exp Ther 267:322-330. (Pubitemid 23325024)
141. White FJ, Appel JB (1982a). Training dose as a factor in LSD-saline discrimination. Psychopharmacology (Berl ) 76:20-25. (Pubitemid 12187356)
142. White FJ, Appel JB (1982b). Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science 216: 535-537. (Pubitemid 12053929)
143. White J-A, Stolerman IP (1996). Reversal of overshadowing in a drug mixture discrimination in rats. Psychopharmacology (Berl) 123:46-54. (Pubitemid 26041527)
144. Wilcox KM, Paul IA, Ordway GA, Woolverton WL (2001). Role of the dopamine transporter and the sodium channel in the cocaine-like discriminative stimulus effects of local anesthetics in rats. Psychopharmacology (Berl) 157: 260-268. (Pubitemid 32905567)
145. Winter JC, Kieres AK, Zimmerman DM, Reissig CJ, Eckler JR, Ullrich T, et al. (2005). The stimulus properties of LSD in C57BL/6 mice. Pharmacol Biochem Behav 81:830-837. (Pubitemid 41187816)
146. Wolff MC, Leander JD (1997). Differentiation of 5-HT1A receptor ligands by drug discrimination. Eur J Pharmacol 333:113-122. (Pubitemid 27387380)
147. Wolff MC, Leander JD (1998). Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon. Eur J Pharmacol 345:35-39. (Pubitemid 28179467)
148. Ybema CE, Slangen JL, Olivier B, Mos J (1993). Dose-dependent discriminative stimulus properties of 8-OH-DPAT. Behav Pharmacol 4:610-624. (Pubitemid 24002276)
149. Ybema CE, Slangen JL, Olivier B (1994). Discriminative stimulus effect of flesinoxan: effects of 5-HT1A antagonists and PCPA. Pharmacol Biochem Behav 47:957-962.
150. York JL (1978). A comparison of the discriminative stimulus effects of ethanol, barbital, and phenobarbital in rats. Psychopharmacology (Berl) 60:19-23. (Pubitemid 9047368)
151. Young R, Glennon RA (2002). Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113-118. (Pubitemid 34603605)
152. Young R, Rosecrans JA, Glennon RA (1983). Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105. Psychopharmacology (Berl ) 80:156-160. (Pubitemid 13095632)
153. Young R, Rosecrans JA, Glennon RA (1986). Further studies on the dose dependent stimulus properties of 5-methoxy-N,N,dimethyltryptamine. Pharmacol Biochem Behav 25:1207-1210. (Pubitemid 17212802)
154. Young AM, Masaki MA, Geula C (1992). Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246-257.
155. Young R, Bondareva T, Wesolowska A, Young S, Glennon RA (2006). Effect of the 5-HT6 serotonin antagonist MS-245 on the actions of (-)nicotine. Pharmacol Biochem Behav 85:170-177. (Pubitemid 44772918)
156. Zhang L, Barrett JE (1991). Imipramine as discriminative stimulus. J Pharmacol Exp Ther 259:1088-1093.
157. Zhang L, Walker EA, Sutherland JII, Young AM (2000). Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology (Berl) 148:136-145. (Pubitemid 30104135)